|
|
Article: Advinus Therapeutics and Merck & Co., Inc. Establish Drug Discovery and Development Collaboration.
- Article from:
- Business Wire
- Article date:
- November 16, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BANGALORE, India & WHITEHOUSE STATION, N.J. -- Advinus Therapeutics (P) Ltd. and Merck & Co., Inc. today announced that they have formed a drug discovery and clinical development collaboration in the area of metabolic disorders.
Advinus and Merck will work together to develop clinically validated drug candidates for metabolic disorders, with Merck retaining the right to advance the most promising of these candidates into late-stage clinical trials. Under the terms of the agreement, Advinus will receive an upfront payment and could potentially receive milestone payments of up to US$74.5 million for each target included in the collaboration. Advinus is also ...